Meetings and Workshops

OEHHA is soliciting information which may be relevant to the evaluation of the following chemicals under consideration for listing as known to the State to cause cancer or reproductive toxicity: Trimetrexate Glucuronate, Paclitaxel, Quazepam, Nitrobenzene, Leuprolide Acetate, Ganciclovir Sodium, Goserelin Acetate, Estropipate, Ethionamide, Atenolol, Amiodarone Hydrochloride, C.I. Direct Blue 15, 3,7-Dinitrofluoranthene, 3,9-Dinitrofluoranthene, 1-Amino-2,4-dibromoanthraquinone, C.I. Direct Blue 218, and Premarin.

In a notice dated September 27, 1996, OEHHA announced that these chemicals were under consideration for listing based on a review of information indicating that the chemicals may meet the criteria set forth in 22 CCR, Section 12306 or Section 12902. OEHHA solicited comments and information relevant to the evaluation of these chemicals in the context of the regulatory criteria for administrative listing under Proposition 65. The public comment period commenced on September 27, 1996, and closed on, November 26, 1996.

Meeting of the Developmental and Reproductive Toxicant Identification Committee to consider listing inorganic arsenic and cadmium.

Comment Period - Request for Information on Chemicals to be Considered by the Carcinogen Identification Committee